Published: Nov. 16, 2012
BaroFold Inc

BaroFold Inc., a pharmaceutical company focused on the patented Pressure Enabled Protein Manufacturing (PreEMT) technology invented in the labs of ChBE Professor Theodore Randolph and Dr. John Carpenter, has recently licensed its technology to both Boehringer Ingelheim and Nuron Biotech.  Read more about these collaborative efforts below:

Boehringer Ingelheim and BaroFold Announce Strategic Agreement on PreEMT™ High Pressure Protein Refolding Technology


Nuron Biotech Completes Enrollment of a Pivotal Phase 3 Study for Proprietary Recombinant Human Interferon Beta-1b (NU100) in Relapsing Remitting Multiple Sclerosis